Please provide your email address to receive an email when new articles are posted on . Treatment with hydroxychloroquine does not impact corrected QT length among patients with rheumatoid arthritis ...

New research shows that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid ...

Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.

Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...

Most men with prostate cancer who are treated with medical castration, also called androgen-deprivation therapy, will have an increase in QT interval, with torsade de pointes and ventricular ...

The idea that someone could have a life-threatening heart condition and not know it is frightening. Worse is the idea that this disease could strike without warning. However, anyone may be walking ...

Mobile electrocardiography (mECG) devices can go places a standard 12-lead electrocardiography system can't, with fewer technicians in tow, but it doesn't have the same functionality — their most ...

LQT-1213 is a first-in-class serum glucocorticoid regulated kinase 1 inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum ...

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences ...